Effects of unilateral intrathecal administrations of low dose tissue- type plasminogen activator on clot lysis, vasospasm and brain phospholipid hydroperoxidation in a primate model of bilateral subarachnoid hemorrhage

Neurological Research

Volumn 20, Issue 7, 1998, Pages 625-631

  Suzuki, Hidenori ^b   Kanamaru, Kenji ^b   Kuroki, Minoru ^b   Sun, Hong ^b   Waga, Shiro ^b   Miyazawa, Teruo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

Cerebral vasospasm; Lipid peroxidation; Phospholipids hydroperoxides; Primate model; SAH; TPA

Indexed keywords

ALTEPLASE; PHOSPHOLIPID;

ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; CONTROLLED STUDY; DRUG INDICATION; INTRATHECAL DRUG ADMINISTRATION; LIPID PEROXIDATION; NONHUMAN; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM;

EID: 0031714437     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1998.11740574     Document Type: Article

References (42)

1. Weir B. Aneurysm Affecting the Nervous System, Baltimore: Williams and Wilkins, 1987: pp. 505-569
2. Romner B, Sonesson B, Ljunggren B, Brandt L, Saveland H, Holtas S. Late magnetic resonance imaging related to neurobehavioral functioning after subarachnoid hemorrhage. Neurosurgery 1989; 25: 390-397
3. Handa Y, Kaneko M, Matuda T, Kobayashi H, Kubota T. In vivo proton magnetic resonance spectroscopy for metaboloic changes in brain during chronic cerebral vasospasm in primates. Neurosurgery 1997; 40: 773-781
4. 2 formation in rat corticocerebral tissues in vitro. Biochem Pharmacol 1996; 52: 97-103
5. Everse J, Hsia N. The toxicities of native and modified hemoglobins. Free Radic Biol Med 1997; 22: 1075-1099
6. Macdonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991; 22: 971-982
7. Handa Y, Weir BKA, Nosko M, Mosewich R, Tsuji T, Grace M. The effect of timing of clot removal on chronic vasospasm in a primate model. J Neurosurg 1987; 67: 558-564
8. Taneda M. Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms. J Neurosurg 1982; 57: 622-628
9. Findlay JM, Weir BKA, Gordon P, Grace M, Baughman R. Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 1989; 24: 491-498
10. Findlay JM, Weir BKA, Kanamaru K, Grace M, Baughman R. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 1990; 26: 201-206
11. Findlay JM, Weir BKA, Kassell NF, Disney LB, Grace MGA. lntracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 181-188
12. Findlay JM, Kassell NF, Weir BKA, Haley EC, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW, Yonas H, Steinbery GK, West M, Winn HR, Ferguson G. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995; 37: 168-178
13. Kajimoto Y, Ohta T, Kuroiwa T. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs. Neurosurgery 1997; 40: 572-577
14. Mizoi K, Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 1993; 78: 430-437
15. Öhman J, Servo A, Heiskanen O. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 197-201
16. Sasaki T, Ohta T, Kikuchi H, Takakura K, Usui M, Ohnishi H, Kondo A, Tanabe H, Nakamura J, Yamada K, Kobayashi N, Ohashi Y. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1994; 35: 597-605
17. Seifert V, Eisert WG, Stolke D, Goetz C. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 1989; 25: 590-598
18. Steinberg GK, Vanefsky MA, Marks MP, Adler JR, Koenig GH. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 1994; 34: 809-814
19. Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmerman RS, Bederson JB. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 189-196
20. Catalyad MV, Catalyad Perez JB, Escario J. Effects of CDP-choline on the recovery of patients with head injury. J Neurol Sci 1991; 103(Suppl.): S15-S18
21. Cuenod CA, Kaplan DB, Michot JL, Jehenson P, Leroy-Willig A, Forette F, Syrota A, Boller F. Phospholipid abnormalities in early Alzheimer's disease. Arch Neurol 1995; 52: 89-94
22. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ. Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 1992; 89: 1671-1675
23. Spiers PA, Myers D, Hochandel GS, Lieberman HR, Wurtman RJ. Citicoline improves verbal memory in aging. Arch Neurol 1996; 53: 441-448
24. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett J, Malla A, Thompson T. An in vivo study of the prefrontal cortex of tPA effect on lipid peroxidation after SAH: Hidenori Suzuki et al. schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry 1995; 52: 399-406
25. 2) activity in gerbil brain: Enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion. J Neurosci 1991; 11: 1829-1836
26. Tazaki Y, Sakai F, Otomo E, Kutsuzawa T, Kameyama M, Omae T, Fujishima M, Sakuma A. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebocontrolled study. Stroke 1988; 19: 211-216
27. Marzatico F, Gaetani P, Silvani V, Lombardi D, Sinforiani E, Baena RR. Experimental isobaric subarachnoid hemorrhage: Regional mitochondrial function during the acute and late phase. Surg Neurol 1990; 34: 294-300
28. Miyazawa T, Suzuki T, Fujimoto K, Kaneda T. Phospholipid hydroperoxide accumulation in liver of rats intoxicated with carbon tetrachloride and its inhibition by dietary α-tocopherol. J Biochem 1990; 107: 689-693
29. Miyazawa T, Yasuda K, Fujimoto K. Chemiluminescence-high performance liquid chromatography of phosphatidylcholine hydroperoxide. Anal Lett 1987; 20: 915-925
30. Miyazawa T, Suzuki T, Fujimoto K, Yasuda K. Chemiluminescent simultaneous determination of phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide in the liver and brain of the rat. J Lipid Res 1992; 33: 1051-1058
31. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358
32. Farrar JK. Hydrogen clearance technique. In: Wood JM, ed. Cerebral Blood Flow, New York: McGraw-Hill, 1987: pp. 275-287
33. Pasztor E, Symon L, Dorsch NWC, Branston NM. The hydrogen clearance method in assessment of blood flow in cortex, white matter and deep nuclei of baboons. Stroke 1973; 4: 556-567
34. 2 clearance. J Cereb Blood Flow Metab 1992; 12: 230-237
35. Miyazawa T, Suzuki T, Fujimoto K, Yasuda K. Determination of phospholipid hydroperoxides using luminol chemiluminescence-high-performance liquid chromatography. Methods Enzymol 1994; 233: 324-332
36. Kiwak KJ, Moskowitz MA, Levine L. Leukotriene production in gerbil brain after ischemic insult, subarachnoid hemorrhage, and concussive injury. J Neurosurg 1985; 62: 865-869
37. Seifert V, Stolke D, Kunz U, Resch K. Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: Experimental study on the pathogenesis of cerebral vasospasm. Neurosurgery 1988; 23: 313-321
38. Janero DR, Burghardt B. Analysis of cardiac membrane phospholipids peroxidation kinetics as malondialdehyde: Nonspecificity of thiobarbituric acid-reactivity. Lipids 1988; 23: 452-458
39. Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in CNS trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 1994; 28: 221-268
40. Hoffman SW, Moore S, Ellis EF. lsoprostanes: Free radicalgenerated prostaglandins with constrictor effects on cerebral arterioles. Stroke 1997; 28: 844-849
41. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci 1990; 10: 1035-1041
42. Cifone MG, Roncaioli P, Maria RD, Camarda G, Santoni A, Ruberti G, Testi R. Multiple pathways originate at the Fas/APO-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J 1995; 23: 5859-5868